Sculptra, PRF & PRP Guides
Your First Sculptra Consultation: What to Ask and How to Prepare
Read the guide
Sculptra, PRF & PRP Guides

In this guide
Your first Sculptra consultation is an opportunity to decide whether the proposed treatment fits your concern. A useful way to prepare is to bring a short record of your goals, health history and previous treatments, then ask for answers you can review afterward. The American Academy of Dermatology recommends gathering this information and asking about suitability, risks and alternatives before receiving a filler. AAD: preparing for a filler consultation.
Use the checklist below to organize that conversation. For a broader look at the appointment itself, read what happens during a filler consultation.
Write down the change you are considering and the features you want to preserve. For example: “I notice this cheek line when I smile, but I want to keep my facial character.” Mention how much uncertainty you are comfortable with and any event influencing your timing. Goals and expected outcomes belong in the consultation discussion. ASPS: dermal filler consultations.
Take these questions with you:
The answers should connect the recommendation to your own concern. You do not need to arrive having chosen a product.
Prepare two short lists. The first covers previous facial treatments: product names, treated areas, approximate dates and any reactions or problems. Include fillers, other injections, resurfacing procedures and facial surgery. If you have a record from a previous practice, bring it; distinguish confirmed details from what you only remember. The second covers medical conditions, allergies and current medicines, vitamins and supplements. These are established consultation topics in ASPS guidance.
Be especially clear about allergies to Sculptra ingredients, severe allergies and raised scars such as keloids or hypertrophic scars. Sculptra labeling includes specific contraindications involving those histories. When lidocaine is added during preparation, a lidocaine allergy is also a contraindication. Also discuss pregnancy or breastfeeding, immune conditions or treatment, bleeding problems and active skin inflammation or infection. Some of these involve unstudied populations or a reason to defer treatment; let the clinician explain what applies to you. Sculptra clinician labeling, pages 2–5.
Bring the names and doses of prescribed and over-the-counter products, including occasional use. Do not change a prescribed medicine on your own to prepare for an aesthetic visit. Ask whether the treating clinician needs to coordinate with your prescriber. The AAD preparation checklist supports full disclosure of medicines and supplements.
Ask the clinician to write down the product name and proposed treatment area, then explain whether that particular use is FDA-approved. The FDA reviews fillers for specified uses; approval for one use does not establish approval for every proposed location. Also ask about the clinician’s training and experience with the product and intended area. FDA: information for patients considering dermal fillers.
Useful questions include:
Ask to take home the current patient labeling. You can compare its benefits, limits and warnings with the explanation you received. The FDA specifically recommends requesting that information before deciding. FDA filler guidance.
Ask how the clinician will distinguish an early appearance from a treatment outcome. The Sculptra patient guide explains that initial fullness can come from swelling and the water used to prepare the product, while correction develops gradually. Early fullness therefore should not be your measure of the final result. Sculptra patient guide, page 9.
Request an explanation of what will be assessed at follow-up, how progress will be documented and what would lead the clinician to pause or reconsider the plan. Write down the expected range of change and its limits. If you have an important date, ask whether the uncertainty is compatible with your plans.
Discuss both early reactions and problems that may appear later. Bruising, swelling, tenderness and other injection-site reactions are reported. Sculptra labeling also describes delayed papules or nodules and reports of granulomas, a type of inflammatory reaction. These are not interchangeable terms, and a new lump needs assessment rather than a self-diagnosis. Sculptra clinician labeling, pages 3 and 24–25.
Ask whom to contact about a new or persistent concern, how to reach help outside regular hours and which symptoms require urgent care. Rare vascular complications can cause skin injury, vision loss or stroke. Seek immediate medical attention for vision changes, unusual pain, white skin near an injection site or stroke symptoms during or shortly after treatment. Sculptra patient guide, pages 3 and 10.
Keep the routine contact instructions and urgent instructions together, in a form you can find quickly. Asking for them before deciding gives you a chance to clarify any uncertainty.
Before you leave, ask for a written summary containing:
For the detailed questions to ask about what a quote includes, use our Sculptra pricing and quote guide. Keep the plan and quote together so you can review the recommendation as a whole.
Calista Aesthetics offers Sculptra in Santa Ana’s South Coast Metro area. You can read the Sculptra service information and review appointment information as you prepare your questions.
Common questions
Tell the clinician what you remember and ask the previous practice for your treatment record. Bring the product name, treated area, approximate date and any reaction information you can obtain. Clearly mark anything uncertain rather than guessing. The ASPS consultation guidance includes prior injections, other facial procedures and surgery among the information to discuss.
No. Age and general health alone do not establish that a treatment suits your concern. Ask what finding supports the recommendation and what benefit is realistic. The FDA-reviewed cheek study involved people with moderate or severe cheek wrinkles; it does not establish a preventive need for treatment in young adults.
A clinician can discuss an expected range and reassessment plan, but an exact result date should not be treated as a promise. The Sculptra patient guide describes gradual correction and explains that initial fullness can reflect temporary swelling and the water used to prepare the product. Bring any important event date into the discussion.
Do not stop or change a prescribed medicine on your own for an aesthetic appointment. Bring a complete list and ask whether anything needs review with the prescribing clinician. The AAD preparation guidance recommends disclosing prescriptions, over-the-counter medicines, vitamins and herbal products.
You can use the consultation to gather information and decide later. Before arranging the visit, ask the practice what appointment type you are booking and what fees or terms apply. Ask for the proposed plan, alternatives and unanswered questions in writing. This is a decision checklist, not a statement of an individual practice’s scheduling policy.